L., Lynn, A., Russell, J
FDA Disclaimer: The content and products mentioned on this website have not been evaluated by the U.S
If storing the medication at home, do not leave it in locations such as the bathroom or car, and keep the medicine out of the reach of children
In the SURPASS-4 trial, adults with T2DM at heightened cardiovascular risk, who were inadequately managed with oral glucose-lowering agents, once-weekly tirzepatide (5 mg, 10 mg, or 15 mg) were compared to insulin glargine (100 U/mL)
If it metastasizes, more advanced treatments like immunotherapy, radiation therapy, or targeted therapy are options to control or eliminate the cancer cells
doi: 10.2165/00007256-199214050-00003 50 OSullivanAJKennedyMCCaseyJHDayROCorriganB